IMS Health, Inc. (RX)
Discount cash flow analysis
Price history
Sensitivity matrix
|
-1% |
Discount Rate % 0% |
1% |
||
|---|---|---|---|---|
| -1% | $23.88 | $23.47 | $23.07 | |
| Terminal Growth% | 0 | $23.99 | $23.58 | $23.17 |
| +1% | $24.10 | $23.69 | $23.28 |
How does a change in discount rate or terminal growth affect valuation?
This table shows the sensitivity of the valuation to two key variables - the discount rate and the terminal growth rate
Valuations and comments
- Valuecruncher created a new valuation of $36.07 (undervalued by 64.1%) - 9 years ago
- Diegoengel created a new valuation of $23.58 (undervalued by 12.07%) - over 11 years ago
- GordonGekko created a new valuation of $16.85 (undervalued by 21.4%) - 12 years ago
Comments
The boring details
| All amounts in millions | Figures |
| Enterprise Value: | 5,198 |
| Net Debt (Long-term borrowings less cash): | 1,188 |
| Equity Value: | 3,838 |
| Number of Shares Outstanding: | 182,000,000 |
| Calculated value per share: | $23.58 |
Enterprise Value is the present value of the post-tax cash flows for a business into the future.
Where:
- C1, C2, C3 - the cash flow in period 1, 2, 3, ...
- r - the discount rate
To capture the cash flows into the future a terminal value is calculated via a perpetuity calculation -
based on the final years forecast post-tax free cash flow.
Where:
- Cn - the cash flow in the final forecast period.
- LTG - the long-term growth rate
- r - the discount rate
- g - the terminal growth rate
The Capital Asset Pricing Model (CAPM) is used to determine the equity component in the discount rate.
Where:
- rt - the risk free rate
- t - the tax rate
- B - the beta of the company
- MRP - the Market Risk Premium
Valuecruncher uses an estimate of Weighted Average Cost of Capital (WACC) to determine the discount rate in the calculation.